Interojo Co

Interojo Co FCF Yield

The Free Cash Flow Yield of Interojo Co (119610.KQ) as of Nov 20, 2026 is 9.77 %. In the previous year, Free Cash Flow Yield was 8.74 % — a change of 11.78% (higher).

FCF Yield

9.77 %

YoY

11.78%

Last updated:

Free Cash Flow Yield of Interojo Co is 2025 9.77 % . Free Cash Flow Yield of Interojo Co was 2024 8.74 % . It decreases by 11.78% higher compared to the previous year.

The Interojo Co FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-2.16 KRW
Jan 1, 2019
4.05 KRW
Jan 1, 2020
-5.03 KRW
Jan 1, 2021
1.66 KRW
Jan 1, 2022
-2.70 KRW
Jan 1, 2023
0.04 KRW
Jan 1, 2024
8.74 KRW
Jan 1, 2025
9.77 KRW
The Interojo Co FCF Yield history
YEARFCF YieldYoY
9.77 %+11.78%
8.74 %+23,054.40%
0.04 %-101.40%
-2.70 %-262.47%
1.66 %-133.01%
-5.03 %-223.99%
4.05 %-287.88%
-2.16 %-170.04%
3.08 %-43.25%
5.43 %+29.13%
4.20 %+123.46%
1.88 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Free Cash Flow Yield of Interojo Co is 9.77 % in 2025.

Free Cash Flow Yield of Interojo Co changed from 8.74 % to 9.77 %, representing a 11.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Interojo Co since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Interojo Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Interojo Co

All Key Metrics — Interojo Co